Interleukin-33 Predicts Poor Prognosis and Promotes Ovarian Cancer Cell Growth and Metastasis Through Regulating ERK and JNK Signaling Pathways

Molecular Oncology - Netherlands
doi 10.1016/j.molonc.2015.06.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

FAM83A Promotes Lung Cancer Progression by Regulating the WNT and Hippo Signaling Pathways and Indicates Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2020English

Author Correction: PRMT1 Promotes Pancreatic Cancer Growth and Predicts Poor Prognosis

Cellular Oncology
MedicineCancer ResearchOncologyMolecular Medicine
2019English

Wnt7a Predicts Poor Prognosis, and Contributes to Growth and Metastasis in Tongue Squamous Cell Carcinoma

Oncology Reports
MedicineCancer ResearchOncology
2019English

STYK1 Promotes Warburg Effect Through PI3K/AKT Signaling and Predicts a Poor Prognosis in Nasopharyngeal Carcinoma

Tumor Biology
MedicineCancer Research
2017English

MAP Kinase-Interacting Serine/Threonine Kinase 2 Promotes Proliferation, Metastasis, and Predicts Poor Prognosis in Non-Small Cell Lung Cancer

Scientific Reports
Multidisciplinary
2017English

MicroRNA‐124‐3p.1 Promotes Cell Proliferation Through Axin1‐dependent WNT Signaling Pathway and Predicts a Poor Prognosis of Triple‐negative Breast Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Upregulation of SIRT6 Predicts Poor Prognosis and Promotes Metastasis of Non-Small Cell Lung Cancer via the ERK1/2/MMP9 Pathway

Oncotarget
Oncology
2016English

HspB5 Correlates With Poor Prognosis in Colorectal Cancer and Prompts Epithelial-Mesenchymal Transition Through ERK Signaling

PLoS ONE
Multidisciplinary
2017English

Association Between Interleukin‑33 and Ovarian Cancer

Oncology Reports
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy